Alnylam Pharmaceuticals
ALNY
#563
Rank
S$53.60 B
Marketcap
S$404.19
Share price
-0.47%
Change (1 day)
25.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company